Albert M. Baehny

     

Albert M. Baehny, a Swiss citizen, holds a degree in biology from the University of Fribourg, Switzerland (CH).   

 

  • Chairperson of the Board of Directors of Lonza Group Ltd (since 2018)
  • Member of the Board of Directors (since April 2017)

 

Current Activities and Functions

Public Company Boards:

  • Member of the Board of Investis Group Holding SA (since 2016)
  • Chairman of the Board of Directors of Geberit (since 2011)

 

Former Activities and Functions

  • CEO of Geberit Group (2005-2014)
  • Head of Group Division Marketing and Sales Europe for Geberit Group (2003–2004)
  • Senior Vice-President at Wacker Chemie AG (2001–2002)
  • Various Marketing, Sales, Strategic Planning and Global Management Positions with:
    • Vantico (2000–2001)
    • Ciba-Geigy / Ciba Specialty Chemicals (1994–2000)
    • Dow Chemicals Europe (1981–1993)
    • Serono-Hypolab (1979–1981)
     
Aebischer Patrick
  

Patrick Aebischer holds a doctorate in medicine from the University of Geneva. He has received numerous honors, including the Robert Bing Prize of the Swiss Academy of Medicine and the Pfizer Foundation Prize for Clinical Neurosciences.

 

  • Member of the Board of Directors (since March 2008), Vice Chairperson

 

Current Activities and Functions

Public Company Boards:
  • Member of the Board of Directors of Logitech SA (since 2016)
  • Member of the Board of Directors of Nestlé SA (since 2015)

 

Further Appointments:

  • Senior Partner of NanoDimension Management Limited (since 2017)
  • Senate member of the Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) (since 2016)
  • Scientific technical committee member of the Italian Institute of Technology (since 2015)
  • Chairman of the Advisory Board of the Novartis Venture Fund (since 2014)
  • Member of the Singapore Biomedical Sciences International Advisory Council (since 2013)
  • Chairman of the Board of Amazentis SA (since 2007)
  • Professor of Neurosciences, Swiss Federal Institute of Technology Lausanne (EPFL) (since 2000)

 

Former Activities and Functions

  • Representative of the EPFL on the boards of various Swiss foundations
  • President of the Swiss Federal Institute of Technology of Lausanne (EPFL) (2000–2016)
  • Member of the Foundation Board of the World Economic Forum (2013–2016)

 
     
Bauer Werner

  

Werner Bauer holds a diploma and PhD in chemical engineering from the University Erlangen-Nürnberg (DE). He has received several scientific honors, among others the BioAlps Award 2011 and Honorary Senator from the Technical University of Munich (DE).

 

  • Member of the Board of Directors of Lonza Group Ltd (since April 2013)

 

Current Activities and Functions

Public Company Boards:

  • Vice-Chairman of the Board of Directors of Givaudan SA (since 2014)

 

Further Appointments:

  • Vice-Chairman of the Supervisory Board of Bertelsmann SE & Co. KGaA (since 2012) and Chairman of the Board of Trustees of the Bertelsmann Foundation (since 2011)
  • Member of the Supervisory Board of SIG Combibloc Group AG (since 2018)

 

Former Activities and Functions

  • Member of the Supervisory Board of GEA Group AG (2011–2018)
  • Chairman of the Supervisory Board of Nestlé Deutschland AG (2007–2017)
  • Executive Vice-President of Nestlé SA, Head of Innovation, Technology, Research and Development (2007–2013)
  • Executive Vice-President of Nestlé SA, Head of Technical, Production, Environment, Research & Development (2002–2007)
  • Various managerial positions of increasing responsibility at Nestlé (1990–2002)
  • Chairman of the Board of Directors of Galderma Pharma SA (2011–2014)
  • Member of the Board of Directors of L’OREAL, France (2005–2012)
  • Member of the Board of Directors of Alcon Inc., Switzerland (2002–2010)
  • Director of the Fraunhofer Institute for Food Technology & Packaging and Professor in Bioprocess Technology at Technical University Munich (1985–1990)
  • Professor of Chemical Engineering at the Technical University of Hamburg (1980–1985)
     
Angelica Kohlmann

  

Angelica Kohlmann, a German-Brazilian citizen, holds a MD and doctorate in medicine from Hamburg University (DE).

 

  • Member of the Board of Directors of Lonza Group Ltd (since May 2018)

 

Current Activities and Functions

(No Public Company Boards)

  • Member International Advisory Board IE University and Business School, Madrid(since 2017)
  • Chairman Board of Directors, Bloom Diagnostics AG (since 2014)
  • Chairman Board of Directors, Kohlmann & Co AG (since 2013)
  • International investor in biotech and tech, based in Switzerland (since 2014)
  • Board Observer Teralytics AG (since 2017)
  • Chairman Advisory Board Peter Drucker Society Europe / Global Peter Drucker Forum, Vienna (since 2009)

 

Former Activities and Functions

  • Member Advisory Board UBS Unique (2017–2018)
  • Director Trinnacle Fund Ltd (2016–2017)
  • Member Board of Directors Teralytics AG (2013–2016)
  • Founder & CEO Ifitech GmbH, Germany (2010–2017)
  • International investor in biotech and tech, based in Germany (2000–2013)
  • International consultant for strategy, management, investments and restructuring (1992–1999)
  • Head global restructuring Behringwerke AG, Germany (1990–1992)
  • Member Board Staff Hoechst AG, Germany (1988–1990)
  • International Marketing Group Leader at Behringwerke AG (1986–1988)
  • MD Anderson Cancer Center, Houston and Memorial Sloan Kettering Cancer Center, New York, USA – various cancer research functions              
     
Christoph Mader

  

Christoph Mäder holds a Master’s degree in Law from the University of Basel (CH) and is admitted to the Swiss Bar.  

 

  • Member of the Board of Directors of Lonza Group Ltd (since April 2016)

 

Current Activities and Functions

Public Company Boards:

  • Member of the Board of EMS Chemie Holding AG (since 2018)
  • Member of the Board of Baloise Holding AG (since 2019)

 

Further Appointments:

  • Member of the Board Committee of economiesuisse (since 2017)
  • Member of the Council of Schweizer Jugend forscht (since 2018)

 

Former Activities and Functions

  • Member of the Group of Executive Committee of Syngenta (2000–2018)
  • Vice-Chairman of economiesuisse (2011–2017)
  • Member of the Executive Board of the Business and Industry Advisory Committee (BIAC) for the Organization for Economic Co-operation and Development (OECD)(2012–2016)
  • Head of Legal & Public Affairs for Novartis Crop Protection AG (1999–2000)
  • Senior Corporate Counsel for Novartis International AG (1992–1998)
  • Member of the Board of scienceindustries (since 2003)
  • Member of the Board of the Basel Chamber of Commerce (since 2002)
     

Richmond Barbara

 

Barbara Richmond holds a first-class degree in management science from the University of Manchester Institute of Science and Technology in England. Barbara Richmond has substantial knowledge as a financial expert, demonstrated by her roles as CFO for various companies. She is a Fellow of the Institute of Chartered Accountants in England and Wales.

 

  • Member of the Board of Directors of Lonza Group Ltd (since April 2014)

 

Current Activities and Functions

Public Company Boards:

  • Group CFO of Redrow plc (since 2010)

 

Former Activities and Functions

  • Group CFO of Inchcape plc (2006–2009)
  • Non-Executive Director and Audit Committee Chair of Scarborough Building Society until its merger with The Skipton Building Society (2005–2009)
  • Non-Executive Director, Senior Independent Director and Audit Committee Chair of Carclo Group plc (2000–2006)
  • Group CFO of Croda International plc (1997–2006) with dual role as Group CFO and President of Active Ingredients and Industrial Chemicals from 2002 to 2006
  • Group CFO of Whessoe plc in 1993 (1993–1997)
  • Various financial roles in Alstom Group SA (1987–1992)
  • Auditor and management consultant for Arthur Andersen (1981–1984)
     
Scheltema Margot

  

Margot Scheltema holds a doctorate in international law from the University of Amsterdam and a master of international affairs (MIA) from Columbia University in New York, NY (USA). Margot Scheltema has substantial knowledge as a finance, corporate governance and risk management expert, demonstrated by her operative roles in finance and management and supervisory roles in the financial sector (bank, central bank, insurance and pension funds).

 

  • Member of the Board of Directors of Lonza Group Ltd (since April 2012)

 

Current Activities and Functions

(No Public Company Boards)

  • NEDAP (NE Director) NV (since 2018)
  • Vice-chair of the Supervisory Board of the Dutch Central Bank (since 2015) (financial institution)
  • Member of the Central Plan Committee Dutch Planning Bureau (since 2014)
  • Chair of the Monitoring Committee of the Dutch Pension Fund Code (since 2014)
  • Council to the Enterprise Chamber of the Amsterdam Court of Appeal (since 2013)
  • Member of the Supervisory Board of Warmtebedrijf Rotterdam (since 2011)
  • Member of the Supervisory Board of TNT Express (since 2011)

 

Former Activities and Functions

  • Vice-Chair of the Supervisory Board of Triodos Bank (2006–2015)
  • Member of the Supervisory Board of ASR NV (2008–2015)
  • External Member of the Audit Committee of the Dutch pension fund ABP (2010 to July 2014) (financial institution)
  • Member of the Supervisory Board of the Rijksmuseum (2007–2015)
  • Member of the AFM External Reporting Committee (2006–2012)
  • Finance Director of Shell Nederland BV (2004–2008)
  • Various managerial positions in finance within the Shell Group (1985–2004)including Senior M&A Adviser for Shell Oil Products Latin America
     
Steinemann Juergen
  

Jürgen Steinemann holds a degree in economics and business management from the European Business School in Wiesbaden (DE), London (UK) and Paris (FR).

 

  • Member of the Board of Directors of Lonza Group Ltd (since April 2014)

 

Current Activities and Functions

Public Company Boards: 

  • Member of the Board of Directors of Barry Callebaut AG (since 2015)
  • Chairman of the Supervisory Board of Metro AG (since 2015)

 

Further Appointments:

  • Investor in food and agro businesses
  • Managing Director of JBS Holding GmbH (since 2017)
  • Chairman of the Supervisory Board of Bankiva B.V. (since 2017)
  • Member of the Advisory Board of Tower Brook Capital Partners LP (since 2017)
  • Member of the Supervisory Board of Big Dutchman AG (since 2015)

 

Former Activities and Functions

  • Chief Executive Officer of Barry Callebaut Ltd (2009–2015)
  • Member of the Board of the Swiss-American Chamber of Commerce (2011–2015)
  • Member of the Executive Board and Chief Operating Officer of Nutreco (2001–2009)
  • Chief Executive Officer of Loders Croklaan (1999–2001)
  • Various senior positions in business-to-business marketing and sales with the former Eridania Béghin-Say Group, ultimately in the «Corporate Plan et Stratégie» unit at the head office in Paris (1990–1998)
     

Olivier Verscheure

  

Olivier Verscheure holds a PhD in computer science from the Swiss Federal Institute of Technology, Lausanne (CH) (EPFL, July 1999).

 

  • Member of the Board of Directors of Lonza Group Ltd (since May 2018) 

 

Current Activities and Functions

(No Public Company Boards)

  • Expert in the Strategy Working Group on Data, Computing and Digital Research lnfrastructures in the State Secretariat for Education, Research and Innovation (SERI) (since 2019)
  • Executive Director of the Swiss Data Science Center, a joint venture between EPFL and ETH Zürich (since 2016)
  • Member of the Executive Committee of Personalized Health and Related Technologies (PHRT), an ETH Domain Strategic Focus Area (since 2017)
  • Co-academic Director, Certificate of Advanced Studies (CAS), Data Science and Management, HEC Lausanne and EPFL (since 2018)

 

Former Activities and Functions

  • Lab Program Director and Senior Research Manager at IBM Research Ireland(2010 – 2016)
  • Research Manager and Senior Member of the Research Staff at the IBM T.J. Watson Research Center (1999 – 2010)